Opening book details…
About this Medicine article
Elbasvir/grazoprevir plus sofosbuvir in treatment-naive and treatment-experienced cirrhotic patients with hepatitis C virus genotype 3 infection treated for 8, 12, or 16 weeks: final results of the C-ISLE study by Foster, G.R. ;Agarwal, K. ;Cramp, M.E. ;Moreea, S. ;Barclay, S. ;Collier, J. ;Brown, A.S. ;Ryder, S.D. ;Ustianowski, A. ;Forton, D.M. ;Fox, R. ;Gordon, F. ;Rosenberg, W.M. ;Mutimer, D.J. ;Du, J. ;Gilbert, C.L. ;Robertson, M. ;Barr, E. ;Haber, B. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Foster, G.R. ;Agarwal, K. ;Cramp, M.E. ;Moreea, S. ;Barclay, S. ;Collier, J. ;Brown, A.S. ;Ryder, S.D. ;Ustianowski, A. ;Forton, D.M. ;Fox, R. ;Gordon, F. ;Rosenberg, W.M. ;Mutimer, D.J. ;Du, J. ;Gilbert, C.L. ;Robertson, M. ;Barr, E. ;Haber, B.
- Publisher
- Elsevier Science; Elsevier ; Elsevier BV; Wiley (ISSN 0168-8278)
- Published
- 2017
- Language
- EN
- Field
- Medicine (Health Sciences)